Goldman Sachs’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,162
| Closed | -$16K | – | 5291 |
|
|
2022
Q3 | $16K | Sell |
2,162
-89
| -4% | -$659 | ﹤0.01% | 5200 |
|
|
2022
Q2 | $14K | Buy |
2,251
+122
| +6% | +$759 | ﹤0.01% | 5476 |
|
|
2022
Q1 | $52K | Buy |
2,129
+167
| +9% | +$4.08K | ﹤0.01% | 5463 |
|
|
2021
Q4 | $94K | Buy |
+1,962
| New | +$94K | ﹤0.01% | 5238 |
|